These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35344302)

  • 21. Mastocytosis and Anaphylaxis.
    Schuch A; Brockow K
    Immunol Allergy Clin North Am; 2017 Feb; 37(1):153-164. PubMed ID: 27886904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts.
    Beyens M; Sabato V; Ebo DG; Zaghmout T; Gülen T
    J Allergy Clin Immunol Pract; 2024 Jul; 12(7):1850-1862.e1. PubMed ID: 38556047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low Frequency of IgE-Mediated Food Hypersensitivity in Mastocytosis.
    Jarkvist J; Brockow K; Gülen T
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3093-3101. PubMed ID: 32534147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs and Vaccines Hypersensitivity in Children with Mastocytosis.
    Mori F; Crisafulli G; Bianchi A; Bottau P; Caimmi S; Franceschini F; Liotti L; Paglialunga C; Saretta F; Caffarelli C
    J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
    Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G
    Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How much specific is the association between hymenoptera venom allergy and mastocytosis?
    Bonadonna P; Zanotti R; Pagani M; Caruso B; Perbellini O; Colarossi S; Olivieri E; Dama A; Schiappoli M; Senna G; Antico A; Passalacqua G
    Allergy; 2009 Sep; 64(9):1379-82. PubMed ID: 19627274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatal hymenoptera venom anaphylaxis by undetected clonal mast cell disorder: A better identification of high risk patients is needed.
    Chatain C; Sedillot N; Thomas M; Pernollet M; Bocquet A; Boccon-Gibod I; Bouillet L; Leccia MT
    Rev Med Interne; 2021 Dec; 42(12):869-874. PubMed ID: 34776279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mastocytosis and Hymenoptera venom allergy.
    Ruëff F; Placzek M; Przybilla B
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):284-8. PubMed ID: 16825870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
    Brockow K; Jofer C; Behrendt H; Ring J
    Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anaphylaxis as part of a clinical diagnosis of mastocytosi - case demonstration].
    Stobiecki M; Sacha M; Czarnobilska E
    Przegl Lek; 2015; 72(12):783-6. PubMed ID: 27024961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for anaphylaxis in patients with mastocytosis.
    Górska A; Niedoszytko M; Lange M; Chełmińska M; Nedoszytko B; Wasąg B; Słomiński JM; Gruchała-Niedoszytko M; Nowicki R; Jassem E
    Pol Arch Med Wewn; 2015; 125(1-2):46-53. PubMed ID: 25578100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder.
    Bonadonna P; Scaffidi L
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):455-468. PubMed ID: 30007463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of serum tryptase in the diagnosis and monitoring of pediatric mastocytosis: a single-center experience.
    Lange M; Zawadzka A; Schrörs S; Słomka J; Ługowska-Umer H; Nedoszytko B; Nowicki R
    Postepy Dermatol Alergol; 2017 Aug; 34(4):306-312. PubMed ID: 28951704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Challenges in the Diagnosis of Pediatric Cutaneous Mastocytosis.
    Ługowska-Umer H; Czarny J; Rydz A; Nowicki RJ; Lange M
    Diagnostics (Basel); 2023 Dec; 13(23):. PubMed ID: 38066824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?
    Matito A; Carter M
    Curr Allergy Asthma Rep; 2015 May; 15(5):22. PubMed ID: 26139333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Evaluation of Hypersensitivity Reactions to Antibiotics in a Large Cohort of Mastocytosis Patients.
    Jarkvist J; Gülen T
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaphylaxis and Mast Cell Disorders.
    Gülen T; Akin C
    Immunol Allergy Clin North Am; 2022 Feb; 42(1):45-63. PubMed ID: 34823750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Criteria for the Regression of Pediatric Mastocytosis: A Long-Term Follow-Up.
    Polivka L; Rossignol J; Neuraz A; Condé D; Agopian J; Méni C; Garcelon N; Dubreuil P; Maouche-Chrétien L; Hadj-Rabia S; Hermine O; Bodemer C
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1695-1704.e5. PubMed ID: 33338682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity.
    Thalappil S; Al-Nesf M
    Qatar Med J; 2022; 2022(2):4. PubMed ID: 35968519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.